Chi Y. Jung
Daegu, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Prognostic factors affecting mortality in elderly, low body mass index, and poor performance status groups with lung cancer: analysis of the 2016 Korean Association of Lung Cancer Registry (KALC-R) database.
Journal: Translational lung cancer research
Published: April 12, 2025
Impact of Modifying Lazertinib Doses on Effectiveness and Safety in Patients With EGFR-Positive Advanced Lung Cancer: A Multicenter, Prospective Observational Cohort Study.
Journal: Thoracic cancer
Published: March 16, 2025
Comparison of metastasis and treatment patterns among different histopathologic types of lung cancer: analysis of 6 years of nationwide lung cancer cohort data in Korea.
Journal: Translational lung cancer research
Published: August 28, 2024
PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC.
Journal: Anticancer research
Published: July 25, 2024
Factors Associated with Postoperative Recurrence in Stage I to IIIA Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation: Analysis of Korean National Population Data.
Journal: Cancer research and treatment
Published: January 19, 2024
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study.
Journal: Clinical lung cancer
Published: December 09, 2023
Real-world outcome of crizotinib for anaplastic lymphoma kinase-positive lung cancer: Multicenter retrospective analysis in South Korea.
Journal: Thoracic cancer
Published: November 06, 2023
Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data.
Journal: Translational lung cancer research
Published: June 12, 2023
Impact of a Psychiatric Consultation Program on COVID-19 Patients: An Experimental Study.
Journal: Psychiatry investigation
Published: October 11, 2022
Five-Year Overall Survival and Prognostic Factors in Patients with Lung Cancer: Results from the Korean Association of Lung Cancer Registry (KALC-R) 2015.
Journal: Cancer research and treatment
Published: April 25, 2022
Bacterial etiology and pneumococcal urinary antigen in moderate exacerbation of chronic obstructive pulmonary disease.
Journal: Journal of thoracic disease
Published: January 29, 2022
Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea.
Journal: Translational lung cancer research
Published: July 07, 2021
Last Updated: 09/26/2026